Open Beta
MetriLume

US marketsRLYB

SEC-sourced researchBeta

RLYB

Rallybio Corp

Company comparison ↗

Data passport

CIK
0001739410
Exchange
Nasdaq
Business activity
— · SIC 2834
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 636,000.0000 USD; December 2025: 858,000.0000 USD858K USD0 USD0December 2024December 2025
RLYB · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2024636,000.0000Mar 16, 2026
December 2025858,000.0000Mar 16, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025858,000.0000-8,978,000.0000-29,813,000.000062,261,000.00004,305,000.0000Mar 16, 2026
December 2024636,000.0000-57,775,000.0000-49,282,000.000068,108,000.00006,454,000.0000Mar 16, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$858KDecember 2025Mar 16, 202610-K
Previous period revenueRevenues$636KDecember 2024Mar 16, 202610-K
Net incomeNetIncomeLoss-$8.98MDecember 2025Mar 16, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$29.81MDecember 2025Mar 16, 202610-K
Total assetsAssets$62.26MDecember 2025Mar 16, 202610-K
Total liabilitiesLiabilities$4.31MDecember 2025Mar 16, 202610-K

New filings

Explore methodology ↗